This site is intended for healthcare professionals

account_circleSign in
Go to /sign-in page

You can view 5 more pages before signing in

Features of advanced disease

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The criteria for advanced phase disease include:

  • increasing splenomegaly despite full doses of cytotoxic therapy
  • rapid white cell doubling
  • white count that responds poorly to cytotoxic therapy
  • anaemia or thrombocytopenia that responds poorly to cytotoxic therapy
  • thrombocytosis >1000x10^9/l
  • 10% blasts in the blood or marrow
  • 20% (blasts + promyelocytes) in the blood or marrow
  • acquisition of "non-random" chromosomal changes in addition to the Ph chromosome
  • myelofibrosis

Reference:

  • Goldman, J. (1997). ABC of clinical haematology. BMJ. 314, 657-660.

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.